The role of interleukin-1 in allergy-related disorders

被引:76
作者
Krause, Karoline [1 ,2 ]
Metz, Martin [1 ,2 ]
Makris, Michael [1 ,3 ]
Zuberbier, Torsten [1 ,2 ]
Maurer, Marcus [1 ,2 ]
机构
[1] Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany
[2] Charite, Autoinflammat Reference Ctr Charite, D-10117 Berlin, Germany
[3] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Dermatol & Venerol 2, GR-11527 Athens, Greece
关键词
allergy; inflammasome; interleukin-1; urticaria; T-LYMPHOCYTE RESPONSE; RECEPTOR ANTAGONIST; NLRP3; INFLAMMASOME; DOUBLE-BLIND; AUTOINFLAMMATORY DISEASE; INDUCED ACTIVATION; PERIODIC SYNDROME; MURINE MODEL; IL-1; CANAKINUMAB;
D O I
10.1097/ACI.0b013e3283574d0c
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Interleukin-1 beta (IL-1 beta) is a potent proinflammatory cytokine, which is involved in many inflammatory conditions including autoinflammatory and allergic disorders. This review provides insights into recent advances of our understanding of the pathogenesis of IL-1 beta-associated allergy-related disorders. Recent findings In autoinflammatory as well as allergic diseases such as contact hypersensitivity, atopic dermatitis and bronchial asthma, dysfunctional inflammasome processing has been demonstrated to account for IL-1 beta-induced inflammation. IL-1-neutralizing drugs have been shown to completely suppress or markedly reduce inflammatory responses in clinical studies and experimental models of urticarial autoinflammatory diseases as well as common allergic disorders. Summary The recent findings support a crucial role for IL-1 beta and inflammasome components in a variety of allergy-related disorders.
引用
收藏
页码:477 / 484
页数:8
相关论文
共 62 条
[21]   Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes [J].
Hoffman, Hal M. ;
Throne, Martin L. ;
Amar, N. J. ;
Sebai, Mohamed ;
Kivitz, Alan J. ;
Kavanaugh, Arthur ;
Weinstein, Steven P. ;
Belomestnov, Pavel ;
Yancopoulos, George D. ;
Stahl, Neil ;
Mellis, Scott J. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (08) :2443-2452
[22]   Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome [J].
Hoffman, HM ;
Mueller, JL ;
Broide, DH ;
Wanderer, AA ;
Kolodner, RD .
NATURE GENETICS, 2001, 29 (03) :301-305
[23]   A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide [J].
Hsu, Li-Chung ;
Ali, Syed R. ;
McGillivray, Shauna ;
Tseng, Ping-Hui ;
Mariathasan, Sanjeev ;
Humke, Eric W. ;
Eckmann, Lars ;
Powell, Jonathan J. ;
Nizet, Victor ;
Dixit, Vishva M. ;
Karin, Michael .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (22) :7803-7808
[24]   Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma [J].
Johnson, VJ ;
Yucesoy, B ;
Luster, MI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (04) :851-858
[25]   Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA [J].
Kanneganti, Thirumala-Devi ;
Body-Malapel, Mathilde ;
Amer, Amal ;
Park, Jong-Hwan ;
Whitfield, Joel ;
Franchi, Luigi ;
Taraporewala, Zenobia F. ;
Miller, David ;
Patton, John T. ;
Inohara, Naohiro ;
Nunez, Gabriel .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) :36560-36568
[26]   Autoinflammatory Disease Reloaded: A Clinical Perspective [J].
Kastner, Daniel L. ;
Aksentijevich, Ivona ;
Goldbach-Mansky, Raphaela .
CELL, 2010, 140 (06) :784-790
[27]   IL-1 Receptor Signaling Is Required at Multiple Stages of Sensitization and Elicitation of the Contact Hypersensitivity Response [J].
Kish, Danielle D. ;
Gorbachev, Anton V. ;
Fairchid, Robert L. .
JOURNAL OF IMMUNOLOGY, 2012, 188 (04) :1761-1771
[28]   INTERLEUKIN-1 RECEPTOR ANTAGONIST SUPPRESSES CONTACT HYPERSENSITIVITY [J].
KONDO, S ;
PASTORE, S ;
FUJISAWA, H ;
SHIVJI, GM ;
MCKENZIE, RC ;
DINARELLO, CA ;
SAUDER, DN .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (03) :334-338
[29]   Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study [J].
Kone-Paut, Isabelle ;
Lachmann, Helen J. ;
Kuemmerle-Deschner, Jasmin B. ;
Hachulla, Eric ;
Leslie, Kieron S. ;
Mouy, Richard ;
Ferreira, Alberto ;
Lheritier, Karine ;
Patel, Neha ;
Preiss, Ralph ;
Hawkins, Philip N. .
ARTHRITIS RESEARCH & THERAPY, 2011, 13 (06)
[30]  
Kontzias A, 2012, SEMIN ARTHRITIS RHEU